Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
18%
OVERLAP
BY WEIGHT
7
# OF OVERLAPPING
HOLDINGS
PJP
29
HOLDINGS
24%
ALSO IN CANC
CANC
49
HOLDINGS
14%
ALSO IN PJP
SECTOR DRIFT (PJP minus CANC)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PJP |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 5.1% | 5.0% | 5.0% |
|
ABBVIE INC | 5.2% | 2.9% | 2.9% |
|
BRISTOL-MYERS SQUIBB CO | 2.6% | 2.9% | 2.6% |
|
GILEAD SCIENCES INC | 4.9% | 1.9% | 1.9% |
|
MERCK & CO. INC. | 4.8% | 1.9% | 1.9% |
PJP Overweight Relative to CANC
|
ABBOTT LABORATORIES | 5.0% |
|
JOHNSON & JOHNSON | 5.0% |
|
PFIZER INC | 4.7% |
|
TRAVERE THERAPEUTICS, INC. | 3.6% |
|
UNITED THERAPEUTICS CORP | 3.5% |
|
GILEAD SCIENCES INC | 3.0% |
|
MERCK & CO. INC. | 2.9% |
|
AMNEAL PHARMACEUTICALS, INC. CLASS A | 2.9% |
|
BIOSANTE PHARMACEUTICALS INC | 2.9% |
|
AMGEN INC | 2.9% |
PJP Underweight Relative to CANC
|
REVOLUTION MEDICINES, INC. | -6.8% |
|
BRIDGEBIO PHARMA, INC. | -4.6% |
 |
GENMAB A/S SPONSORED ADR | -4.6% |
 |
ROCHE HOLDINGS LTD-SPONS ADR | -4.5% |
|
NOVARTIS AG | -4.4% |
 |
ASTRAZENECA PLC | -4.2% |
 |
MERUS N.V. | -4.0% |
|
ARCELLX, INC. | -3.7% |
|
NUVALENT, INC. CLASS A | -3.5% |
|
EXELIXIS INC | -3.0% |